---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-118934"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:12:11.532441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Capricor Therapeutics prices $150M public offering of 6M shares at $25/sh

## Summary
- Offering 6,000,000 shares at $25.00 per share; expected gross proceeds ~$150M.
- Underwriters granted 30-day option to purchase up to 900,000 additional shares.
- Net proceeds for product candidate development, manufacturing, working capital, and corporate purposes.
- Joint book-running managers: Piper Sandler & Co. and Oppenheimer & Co.; co-manager: H.C. Wainwright & Co.
- Offering expected to close on or about December 8, 2025, subject to customary conditions.

## SEC filing metadata
- accession: 0001104659-25-118934
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/0001104659-25-118934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/capr-20251205x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-118934
- JSON: https://secwatch.observer/filing/0001104659-25-118934.json
- Plain text: https://secwatch.observer/filing/0001104659-25-118934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.